prulifloxacin
Sponsors
Merck Sharp & Dohme LLC, Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), University Of Perugia, Lee's Pharmaceutical Limited
Conditions
Acute Bacterial GastroenteritisAcute Exacerbations of Chronic BronchitisAcute Gastroenteritis in Adult TravelersAcute Lower Urinary Tract InfectionUrinary Tract Infection
Phase 2
Phase 3
Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea
CompletedNCT00392574
Start: 2006-08-31End: 2008-03-31Updated: 2015-05-15
Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers
CompletedNCT00448422
Start: 2006-12-31End: 2008-08-31Updated: 2010-09-27
A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control
NCT02157571
Start: 2013-06-30End: 2014-09-30Target: 360Updated: 2014-06-06
A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control
CompletedNCT02439632
Start: 2014-02-28End: 2015-07-31Target: 216Updated: 2015-07-16